Addressing Concerns with Genetic Testing Across Communities of Color

Communities of color have a historical mistrust of genetic testing, with particular concern about how genetic information may be shared outside of its intended purpose. This mistrust may prevent clinicians from having a full understanding of a patient which could lead to a more beneficial treatment.

This GeneSight Cares webinar seeks to educate and inform clinicians that using the GeneSight test to help with treatment of mental health conditions may also be a tool for health equity. We will address Myriad’s commitment to patient privacy and overcoming barriers such as cost.

Our panelists for this webinar are:

Dr. Bernie Ranchero, Medical Director, Leadwell Division of the Hospital Sisters Health System in Charleston, Illinois.

Dr. Gus Alva, Founder and Medical Director of ATP Clinical Research in Costa Mesa, California, a true visionary in various treatment methods for mental health disorders.

Dr. Angela Shannon, Medical Director and Founder of the Positive Balance Wellness Center in Atlanta, Georgia, who has truly expanded how mental health is viewed in her community, opening a mental health clinic in her church.

Our moderator is Asti Jackson, PhD, a Medical Science Liaison with Myriad Genetics.

Attendees can expect to:
Gain a better understanding of the sub-analysis of our GUIDED study that looked specifically at Black and Hispanic/Latino individuals compared to overall results

Increase confidence in our commitment to privacy

Learn how GeneSight is helping break down barriers around cost — both through our affordability offerings and through savings on unnecessary trial and error of medications.